# Estrella Immunopharma, Inc. (ESLAW)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ESLAW/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -13.38M | $ -1.83M | $ 0 | $ -10.37M |
| 2024 | $ 0 | $ -9.30M | $ -8.03M | $ 0 | $ 143.7K |
| 2023 | $ 0 | $ -3.28M | $ -7.54M | $ 0 | $ 9.05M |
| 2022 | $ 0 | $ -4.85M | $ 38.56M | $ 50.0K | $ -6.48M |
| 2021 | $ 0 | $ -257.9K | $ -54.09M | $ 0 | $ 44.18M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -1.31 |
| Current Ratio | 0.12 |

## Other views

- [Metrics](https://sponda.capital/en/ESLAW.md)
- [Charts](https://sponda.capital/en/ESLAW/charts.md)
- [Compare](https://sponda.capital/en/ESLAW/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.